Shares of Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report) shot up 10.8% on Friday . The company traded as high as $44.30 and last traded at $44.30. 809 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 2,400 shares. The stock had previously closed at $40.00.
Bone Biologics Price Performance
The company has a 50-day moving average price of $29.88 and a 200-day moving average price of $46.95.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Further Reading
- Five stocks we like better than Bone Biologics
- Stock Sentiment Analysis: How it Works
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Election Stocks: How Elections Affect the Stock Market
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- The 3 Best Retail Stocks to Shop for in August
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
